Er:YAG Laser Assisted Treatment of Central Odontogenic Fibroma of the Mandible

Monteiro, Luís Silva; Martins, Marco Antônio Trevizani; Pacheco, José Júlio; Salazar, Filomena; Magalhães, João; Vescovi, Paolo; Meleti, Marco

doi:10.1155/2015/230297

Cited by 7 publications

(11 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Peripheral odontogenic fibroma presents as a gingival mass, resembling fibrous hyperplasia. The peripheral type occurs twice as often in females than males and the incidence peak is between second to fourth decades of life ( 32 , 33 ).…”

Section: Odontogenic Benign Tumors Mesenchymalmentioning

confidence: 99%

See 1 more Smart Citation

Odontogenic Tumors. Where Are We in 2017?

Wright

Tekkeşın

2017

J Istanbul Univ Fac Dent

View full text Add to dashboard Cite

Odontogenic tumors are a heterogeneous group of lesions of diverse clinical behavior and histopathologic types, ranging from hamartomatous lesions to malignancy. Because odontogenic tumors arise from the tissues which make our teeth, they are unique to the jaws, and by extension almost unique to dentistry. Odontogenic tumors, as in normal odontogenesis, are capable of inductive interactions between odontogenic ectomesenchyme and epithelium, and the classification of odontogenic tumors is essentially based on this interaction. The last update of these tumors was published in early 2017. According to this classification, benign odontogenic tumors are classified as follows: Epithelial, mesenchymal (ectomesenchymal), or mixed depending on which component of the tooth germ gives rise to the neoplasm. Malignant odontogenic tumors are quite rare and named similarly according to whether the epithelial or mesenchymal or both components is malignant. The goal of this review is to discuss the updated changes to odontogenic tumors and to review the more common types with clinical and radiological illustrations.

show abstract

Section: Odontogenic Benign Tumors Mesenchymalmentioning

confidence: 99%

“…Recurrence is rare. It has been reported that recurrence occurs due to insufficient removal of the lesion ( 32 , 33 )…”

Section: Odontogenic Benign Tumors Mesenchymalmentioning

confidence: 99%

Odontogenic Tumors. Where Are We in 2017?

Wright

Tekkeşın

2017

J Istanbul Univ Fac Dent

View full text Add to dashboard Cite

show abstract

“…(5,23) Odontogenic fibroma is a rare OT, relatively common in females and the incidence peak is between second to fourth decades of life. (52,53) In this study, odontogenic fibroma constituted 7.69% of OTs, no sex predilection, equal occurence in maxilla and mandible were observed. These contradicted studies referring to the common occurrence in females.…”

Section: Discussionmentioning

confidence: 46%

Latest update of odontogenic tumors in Alexandria University, Egypt: A 5-year retrospective study using WHO 2017 classification

Noureldin

Ragab

2019

Egyptian Dental Journal

View full text Add to dashboard Cite

PURPOSE: This retrospective study was intended to assess the frequency and distribution of different types of odontogenic tumors relative to the WHO 2017 latest updates, by reviewing the records of the oral and maxillofacial department, faculty of dentistry in Alexandria throughout a 5-year period. METHODS: The records related to the years January 2014 till December 2018 at the oral and maxillofacial department of the faculty of dentistry in Alexandria were inspected. The odontogenic tumors were investigated for the frequency, gender, age, site. The data was recorded then analyzed using Microsoft Excel 2016. RESULTS: Two hundred and fifteen tumors were documented, out of which 26 (12.09 %) cases confirmed the diagnosis of odontogenic tumors (OTs). 15 (57.69%) of the assessed OTs occurred in females while 11 (42.31%) were seen in males. The average age of the patients was 28.65 ranging between 7 and 73 years. Benign odontogenic tumors comprised 23 (88.46%) cases while 3 (11.54%) cases were malignant. 14 (53.85%) of the assessed OTs were located in mandible the while 12 (46.15%) were in the maxilla. The odontoma was found to be the most prevalent OT represented in 9 (34.62%) cases followed by ameloblastoma in 4 (15.38%) cases. CONCLUSIONS: Differences between our findings and those of previous studies of various populations were witnessed. OTs may greatly diverge according to the version of classification used and by the sample size of the study.

show abstract

“…The histological subtype of COF was indeterminate in 37% of cases. Otherwise the distribution between the complex type and the simple type appeared to be almost equivalent with 34.1% of cases [8,15,21,23,26,[28][29][30][34][35][36][37]39,40,46,47,[50][51][52][53][54]56,57,60,61,63,65,[70][71][72][73][74]76,78,80,82,85] and 28.9% of cases respectively [6,7,[11][12][13][14]17,18,20,22,24,25,27,31,…”

Section: Histological Featuresmentioning

confidence: 99%

Central Odontogenic Fibroma: characteristics and management

Bennabi

Lesclous

Cloître

2021

J Oral Med Oral Surg

View full text Add to dashboard Cite

Introduction: Central Odontogenic Fibroma (COF) is a rare benign odontogenic tumour of the jaws. Until its recent change in classification by the WHO in 2017, this entity has gone without an agreed upon definition for many years. For this reason, COF would remain largely unknown to practitioners. Corpus: The pedagogical objectives of this article are, through a systematic review of the literature using the PRISMA methodology, to list the epidemiological, aetiological, clinical, radiological, histological, therapeutic and prognostic characteristics of COF. All the data collected made it possible to establish a COF management summary for practitioners in order to optimize it. Conclusion: Based on the 135 cases listed, it appears that surgical enucleation is the treatment of choice for COF. The recurrence rate is low and malignant transformation has never been reported. However, regular clinical and radiological follow-up of patients over several years seems to be a justified precaution.

show abstract

Er:YAG Laser Assisted Treatment of Central Odontogenic Fibroma of the Mandible

Cited by 7 publications

References 33 publications

Odontogenic Tumors. Where Are We in 2017?

Odontogenic Tumors. Where Are We in 2017?

Latest update of odontogenic tumors in Alexandria University, Egypt: A 5-year retrospective study using WHO 2017 classification

Central Odontogenic Fibroma: characteristics and management

Contact Info

Product

Resources

About